Month: September 2025

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program

Written by Customer Service on September 30, 2025. Posted in Public Companies.

Watch the “What This Means” video here Featuring Company’s second-generation T-Cell Engager program and advantages over first-generation Company’s T-Cell Engager program has made improvements in manufacturability, preclinical safety profile, and ability to treat a wide spectrum of solid tumors MIRAMAR, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today announced that Peter Rhode, PhD, Chief Scientific Officer and Vice President of Clinical Operations of HCW Biologics, participated in a Virtual Investor “What This Means” segment. As part of the segment,...

24/7 Market News: Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs

Written by Customer Service on September 30, 2025. Posted in Public Companies.

DENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights the opportunity for recombinant spider silk produced by Kraig Biocraft Laboratories (OTCQB: KBLB), the global leader in the development and commercialization of spider silk. 24/7 Market News believes that some of the most obvious projected use-cases include compression gear, perspiration-wicking layers, temperature-regulating base layers, apparel for skiing, snowboarding, skateboarding, and contact sports. Spider silk’s natural properties, lightweight toughness, high elasticity, breathability, and thermal regulation, make it particularly suitable for athletic settings. As more consumers seek gear that performs and aligns with sustainability, spider silk...

PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress

Written by Customer Service on September 30, 2025. Posted in Public Companies.

The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world’s leading surgical conferences PETACH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Dr. Shmuel Sharoni will present the topline results from the Company’s successful Phase 3 SHIELD II trial of D-PLEX₁₀₀ at the upcoming 2025 American College of Surgeons (ACS) Clinical Congress in Chicago, IL. Dr. Shmuel Sharoni will deliver a presentation titled “Efficacy Of A Novel Local Prolonged-release Incisional Doxycycline On Surgical Site Infection Prophylaxis In Abdominal Colorectal Surgery: The Shield II Phase 3 Randomized Clinical Trial,” during...

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Written by Customer Service on September 30, 2025. Posted in Public Companies.

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediatric care and underscore Nuwellis’ commitment to pediatric innovation and integrated cardio-renal care MINNEAPOLIS, Sept. 30, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys, today announced findings from the ULTRA-Peds registry, a multi-center observational study examining the real-world use of the Aquadex System in children with acute kidney injury (AKI), fluid overload, or congenital kidney failure. The ULTRA-Peds registry...

ADT Announces $1.0 Billion Notes Offering

Written by Customer Service on September 30, 2025. Posted in Public Companies.

BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, is proposing to issue and sell $1.0 billion aggregate principal amount of first-priority senior secured notes due 2033 (the “Notes”) in an offering that will be exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”) (the “Offering”). The Company intends to use the proceeds from the Offering, together with the proceeds from the incurrence of an additional $300 million principal amount of incremental first lien senior secured term loans and cash on hand, to fund the redemption of all $1.3 billion outstanding 6.250% Second-Priority Senior Secured Notes due 2028 (the “Second-Priority Notes”) issued...

NeoVolta Reports Fiscal Year 2025 Revenues of $8.4 Million, up 219% from Year Ago

Written by Customer Service on September 30, 2025. Posted in Earnings Releases And Operating Results.

Delivered $4.8 million in fiscal Q4 2025 revenues, more than doubling fiscal Q3 2025 SAN DIEGO, Sept. 30, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable storage, for resilient residential and commercial power infrastructure, reported fiscal Q4 and full year results for the period ending June 30, 2025. “By executing our go-to-market strategy of expanding distribution, driving dealer growth, introducing new products, and improving unit economics, we dramatically accelerated our growth momentum in 2025. Converting our growing pipeline, we delivered record revenues, up 219% in fiscal 2025 from fiscal 2024 fueled by fiscal Q4 2025 contributions that increased 135% sequentially from fiscal Q3 2025,” said Ardes Johnson, CEO of NeoVolta. “This is only the start. Our strengthened...

BTC Development Corp. Announces Pricing of $220,000,000 Initial Public Offering

Written by Customer Service on September 30, 2025. Posted in Public Companies.

PHILADELPHIA, PA, Sept. 30, 2025 (GLOBE NEWSWIRE) — BTC Development Corp (NASDAQ:BDCIU) (the “Company”) today announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market under the symbol “BDCIU” and will begin trading on September 30, 2025. Each unit issued in the offering consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NASDAQ under the symbols “BDCI” and “BDCIW,” respectively. No fractional warrants will be issued upon separation of the units...

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

Written by Customer Service on September 30, 2025. Posted in Public Companies.

BERKELEY, Calif. and MAINZ, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce its participation in the upcoming Colorectal Cancer (CRC) Screening Committee Plenary Meeting and Expert Working Group (EWG) Sessions hosted by the World Endoscopy Organization (WEO), taking place on October 3rd, 2025, in Berlin, Germany. This high-level gathering brings together global leaders in colorectal cancer screening to evaluate emerging technologies, exchange scientific insights, and help shape future strategies for early detection and prevention of CRC. As part of the session titled “Evaluation of New Tests”, Dr. Lena Krammes, Senior Scientist at Mainz Biomed, will...

Rigetti Announces Purchase Orders for Two Quantum Computing Systems Totaling Approximately $5.7 Million

Written by Customer Service on September 30, 2025. Posted in Public Companies.

BERKELEY, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, announced today that it has secured purchase orders totaling approximately $5.7 million for two 9-qubit Novera™ quantum computing systems. Both systems are upgradeable, allowing the customers to increase the system qubit count for more complex computations and research. Delivery for both systems is expected in the first half of 2026. One system is being purchased by an Asian technology manufacturing company. The system will serve as a testbed to develop internal quantum computing expertise. They also plan to benchmark and validate their own quantum computing technologies with the Novera system. The other system is being purchased by a California-based...

Alpine Testing Solutions Inc. Acquired by Volaris Group

Written by Customer Service on September 30, 2025. Posted in Mergers And Acquisitions.

Volaris enters Workforce Management vertical TORONTO, Sept. 30, 2025 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Alpine Testing Solutions Inc., a leader in psychometric consulting and test security services for credentialing and licensure programs. Founded in 1991 and based in Orem, Utah, Alpine Testing Solutions Inc. provides expertise and solutions to help organizations create and maintain high-quality assessment programs that are fair, reliable, and defensible. “Alpine Testing Solutions Inc. has built a trusted reputation in professional certification, helping organizations worldwide uphold the integrity and value of their credentialing programs,” says Mike Borello, Group Leader, Volaris Group. “We are proud to welcome Alpine into Volaris Group and to support their next chapter of growth with a permanent...

Month: September 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals